Pantothenic Acid (Vitamin B5)
Of 10,036 on-market pantothenic acid (vitamin b5) products in the January 2026 DSLD dump, the median declared dose is 12.5 mg, and 100.0% list Calcium Pantothenate as the primary form.
Form share
Of 9,536 products with an identifiable primary form, here is the share held by each form of Pantothenic Acid (Vitamin B5) on the market today.
| Form | Quality tier | n | Share |
|---|---|---|---|
| Calcium Pantothenate | Tier 1 | 9,536 | 100.0% |
Form share over time
Entry-year breakdown of the top forms, 2012–2025.
Dose distribution
Deciles of declared dose per serving (mg), among 9,370 products with a disclosed amount, against the RDA of 5.
- 97.8% of products fall below the fairy-dust threshold (440 mg, 20% of the studied low dose).
- 0.4% of products don't disclose an amount because Pantothenic Acid (Vitamin B5) is declared inside a proprietary blend.
By dosage form
By target group
Top brands
Forms explained
Elemental fraction: 92.0% (pantothenic-acid-equivalent; calcium pantothenate MW 476.53 contains two pantothenate units (confirmed PubChem formula))
The standard, near-universal commercial form because free pantothenic acid is an unstable, hygroscopic oil unsuitable for tableting; no documented inferior-bioavailability concern for the calcium salt.
Source: eCFR 21 CFR 184.1212; PubChem CID 443753
Reference values
- RDA (adult): 5 mg — Adequate Intake, no RDA established: 5mg/day for adults (insufficient data to derive an EAR)
- Tolerable Upper Intake Level (adult): not established — Not established -- no reports of toxicity in humans at high intakes; anecdotal GI distress (diarrhea) at ~10g/day, data insufficient for a UL
- Studied clinical dose range: 2200–2200 mg
- Yang M et al. 2014, Dermatol Ther (Heidelb) 4:93-101, PMID 24831048 -- RCT, a pantothenic-acid-based supplement (2.2g/day total) reduced facial acne lesion counts vs placebo over 12 weeks; well tolerated. Single dose level tested.
- Note: "D-Calcium Pantothenate"/"Calcium D-Pantothenate"/"Calcium Pantothenate" are the same compound, redundant DSLD naming variants.